Next earnings date: 22 Oct 2025
ResMed Inc. – LSE:0KW4.L
ResMed stock price today
ResMed stock price monthly change
ResMed stock price quarterly change
ResMed stock price yearly change
ResMed key metrics
Market Cap | 34.11B |
Enterprise value | 34.65B |
P/E | 30.77 |
EV/Sales | 7.20 |
EV/EBITDA | 20.54 |
Price/Sales | 7.12 |
Price/Book | 6.59 |
PEG ratio | -38.61 |
EPS | 6.51 |
Revenue | 4.35B |
EBITDA | 1.41B |
Income | 957.71M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 23.15% |
Oper. margin | 29.5% |
Gross margin | 57.2% |
EBIT margin | 29.5% |
EBITDA margin | 32.42% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeResMed stock price history
ResMed stock forecast
ResMed financial statements
| Jun 2022 | 914.73M | 195.06M | 21.32% |
|---|---|---|---|
| Mar 2023 | 1.11B | 232.5M | 20.82% |
| Jun 2023 | 1.12B | 229.66M | 20.47% |
| Mar 2024 | 1.19B | 300.49M | 25.1% |
| Sep 2025 | 1.27B | 318.88M | 24.98% |
|---|---|---|---|
| Dec 2025 | 1.35B | 350.65M | 25.83% |
| Mar 2026 | 1.35B | 347.35M | 25.55% |
| Jun 2026 | 1.38B | 362.48M | 26.13% |
Analysts Price target
Financials & Ratios estimates
| 2024-10-24 | 2.05 | 2.11 |
|---|
| Payout ratio | 26.02% |
|---|
| 2020 | 0.81% |
|---|---|
| 2021 | 0.63% |
| 2022 | 0.8% |
| 2023 | 0.81% |
| 2024 | 1.03% |
| Dec 2022 | 6676104000 | 2.93B | 44.01% |
|---|---|---|---|
| Mar 2023 | 6713879000 | 2.78B | 41.43% |
| Jun 2023 | 6751708000 | 2.62B | 38.83% |
| Mar 2024 | 6814562000 | 2.18B | 32.06% |
| Jun 2022 | 79.48M | -55.24M | 57.49M |
|---|---|---|---|
| Mar 2023 | 282.56M | -28.10M | -279.55M |
| Jun 2023 | 237.43M | -46.52M | -188.59M |
| Mar 2024 | 402.03M | -33.15M | -335.91M |
ResMed alternative data
| Aug 2023 | 8,160 |
|---|---|
| Sep 2023 | 10,140 |
| Oct 2023 | 10,140 |
| Nov 2023 | 10,140 |
| Dec 2023 | 10,140 |
| Jan 2024 | 10,140 |
| Feb 2024 | 10,140 |
| Mar 2024 | 10,140 |
| Apr 2024 | 10,140 |
| May 2024 | 10,140 |
| Jun 2024 | 10,140 |
| Jul 2024 | 10,140 |
ResMed other data
| Insider | Compensation |
|---|---|
Mr. Michael J. Farrell BE, SM, MBA (1972) Chief Executive Officer & Director | $2,730,000 |
Mr. Robert A. Douglas (1960) Pres & Chief Operating Officer | $1,990,000 |
Dr. James R. Hollingshead Ph.D. (1963) Pres of Sleep & Respiratory Care Bus. | $1,270,000 |
Mr. Raj Sodhi (1973) Pres of Software as a Service Bus. (SaaS) | $1,040,000 |
| Mr. Brett A. Sandercock (1967) Chief Financial Officer | $907,650 |
Dr. Peter C. Farrell A.M., Ph.D., BE (Hons), ScD, AM (1942) Founder & Non-Executive Chairman | $431,800 |
Mr. Kaushik Ghoshal Chief Technology Officer | |
Ms. Constance C. Bienfait Director of Investor Relations | |
Mr. David B. Pendarvis Chief Admin. Officer, Global Gen. Counsel & Sec. | |
Ms. Amy Wakeham Vice President of Investor Relations & Corporation Communications |
-
What's the price of ResMed stock today?
One share of ResMed stock can currently be purchased for approximately $257.86.
-
When is ResMed's next earnings date?
ResMed Inc. is estimated to report earnings on Wednesday, 22 Oct 2025.
-
Does ResMed pay dividends?
Yes, ResMed pays dividends and its trailing 12-month yield is 0.87% with 26% payout ratio. The last ResMed stock dividend of $0.39 was paid on 18 Jun 2020.
-
How much money does ResMed make?
ResMed has a market capitalization of 34.11B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10.95% to 4.69B US dollars. ResMed earned 1.02B US dollars in net income (profit) last year or $2.11 on an earnings per share basis.
-
What is ResMed's stock symbol?
ResMed Inc. is traded on the LSE under the ticker symbol "0KW4.L".
-
What is ResMed's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of ResMed?
Shares of ResMed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ResMed's key executives?
ResMed's management team includes the following people:
- Mr. Michael J. Farrell BE, SM, MBA Chief Executive Officer & Director(age: 53, pay: $2,730,000)
- Mr. Robert A. Douglas Pres & Chief Operating Officer(age: 65, pay: $1,990,000)
- Dr. James R. Hollingshead Ph.D. Pres of Sleep & Respiratory Care Bus.(age: 62, pay: $1,270,000)
- Mr. Raj Sodhi Pres of Software as a Service Bus. (SaaS)(age: 52, pay: $1,040,000)
- Mr. Brett A. Sandercock Chief Financial Officer(age: 58, pay: $907,650)
- Dr. Peter C. Farrell A.M., Ph.D., BE (Hons), ScD, AM Founder & Non-Executive Chairman(age: 83, pay: $431,800)
- Mr. Kaushik Ghoshal Chief Technology Officer
- Ms. Constance C. Bienfait Director of Investor Relations
- Mr. David B. Pendarvis Chief Admin. Officer, Global Gen. Counsel & Sec.
- Ms. Amy Wakeham Vice President of Investor Relations & Corporation Communications
-
Is ResMed founder-led company?
Yes, ResMed is a company led by its founder Dr. Peter C. Farrell A.M., Ph.D., BE (Hons), ScD, AM.
-
How many employees does ResMed have?
As Jul 2024, ResMed employs 10,140 workers.
-
When ResMed went public?
ResMed Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is ResMed's official website?
The official website for ResMed is resmed.com.
-
Where are ResMed's headquarters?
ResMed is headquartered at 9001 Spectrum Center Boulevard, San Diego, CA.
-
How can i contact ResMed?
ResMed's mailing address is 9001 Spectrum Center Boulevard, San Diego, CA and company can be reached via phone at 858 836 5000.
ResMed company profile:
ResMed Inc.
resmed.comLSE
9,980
Medical - Equipment & Services
Healthcare
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
San Diego, CA 92123
:
ISIN: US7611521078
:
